Skip to main content

Month: August 2020

Eagle Growth and Income Opportunities Fund Announces Second Liquidating Cash Distribution and Deferment of Transfer of Reserve to Liquidating Trust

BOSTON, Aug. 20, 2020 (GLOBE NEWSWIRE) — Eagle Growth and Income Opportunities Fund (the “Fund”) (formerly NYSE: EGIF) today announced its second liquidating cash distribution and a deferment of the estimated date on which it had anticipated contributing certain of its net assets to a liquidating trust in complete liquidation of the Fund.  The deferment is due to recent developments, as discussed below, in connection with claims threatened, as previously announced, by the Fund’s former investment adviser, Four Wood Capital Advisors, LLC (“FWCA”), and its parent, Four Wood Capital Partners, LLC (together with FWCA, “Four Wood”), as a result of a decision by a majority of the Fund’s Trustees, after months of review, to pursue a strategic alternative for the Fund other than the one for...

Continue reading

Laurentian Bank Financial Group to announce Third Quarter 2020 Financial Results on September 4

MONTREAL, Aug. 20, 2020 (GLOBE NEWSWIRE) — Laurentian Bank Financial Group (TSX: LB) will release its third quarter 2020 financial results on Friday, September 4. It will also hold a conference call for media representatives and the financial community at 9:00 a.m. (ET). The quarterly Report to Shareholders, Supplementary Financial Information and presentation slides will be posted on https://lbcfg.ca/investors-centre/, under the Financial Results section, prior to the conference call.About Laurentian Bank Financial GroupFounded in 1846, Laurentian Bank Financial Group is a diversified financial services provider whose mission is to help its customers improve their financial health. The Laurentian Bank of Canada and its entities are collectively referred to as Laurentian Bank Financial Group (the “Group” or the “Bank”).With more...

Continue reading

Banque Laurentienne Groupe Financier présentera ses résultats financiers du 3e trimestre 2020 le 4 septembre

MONTRÉAL, 20 août 2020 (GLOBE NEWSWIRE) — Banque Laurentienne Groupe Financier (TSX : LB) présentera ses résultats financiers du troisième trimestre 2020 le vendredi 4 septembre. Il tiendra également une conférence téléphonique pour les représentants des médias et la communauté financière à 9 h 00 (HE). Le rapport trimestriel aux actionnaires, les informations additionnelles et les diapositives de la présentation seront publiés sur le site https://blcgf.ca/centre-dinvestisseur/ sous la section Résultats financiers avant le début de la conférence téléphonique.À propos de Banque Laurentienne Groupe FinancierFondé en 1846, Banque Laurentienne Groupe Financier est un fournisseur de services financiers diversifiés dont la mission est d’aider ses clients à améliorer leur santé financière. La Banque Laurentienne du Canada et ses entités...

Continue reading

Berry Corporation (bry) Hires Fernando Araujo as New Chief Operating Officer

DALLAS, Aug. 20, 2020 (GLOBE NEWSWIRE) — Berry Corporation (bry)(NASDAQ: BRY) announced that industry veteran Fernando Araujo is joining the Company as Executive Vice President and Chief Operating Officer to succeed retiring COO Gary Grove.Mr. Araujo joins Berry with 30 years of experience having worked for some of the most accomplished brands in the industry including Shell Oil, Repsol S.A., Apache Corporation, and Schlumberger. He has most recently served as Schlumberger Production Management’s Director for Western Hemisphere Assets based out of Houston, Texas. In this role he has been responsible for over 260,000 BOE per day of production from fields in Argentina, Ecuador, Colombia, Mexico, USA, and Canada.“We are excited to welcome Fernando to the Berry team. Fernando’s wealth of knowledge and experience will be a great complement...

Continue reading

Junshi Biosciences and Impact Therapeutics Establish Joint Venture to Develop PARP Inhibitor Senaparib (IMP4297) in China

SHANGHAI and NANJING, China, Aug. 20, 2020 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, and Impact Therapeutics, a privately held clinical-stage biopharmaceutical company devoted to the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality, annouced today that they reached a strategic agreement to establish a joint venture focusing on the research and development and commercialization of PARP inhibitor, a small moleule anti-tumor agent.Under the agreement, Junshi Biosciences will contribute at most RMB 300 million in cash, representing 50% of the registered capital of the JV company. Impact Therapeutics will contribute by way of injection...

Continue reading

Allstar Health Brands, Inc. CEO Discusses Recent News and Covid-19 Testing Efforts in a New Audio Interview with SmallCapVoice.com

AUSTIN, Texas, Aug. 20, 2020 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. (“SCV”) today announces the availability of a new interview with AllStar Health Brands Inc. (OTC PINK:ALST), a specialty pharmaceutical and nutritional supplements company. President Dr. Daniel Bagi discusses the development of the Company’s business model and the distribution agreement for Mexico and other Latin American countries through its new partnership with TPT Global Tech.The full interview can be heard at: https://www.smallcapvoice.com/8-20-20-smallcapvoice-interview-allstar-health-brands-alst/.Speaking with SCV’s Stuart Smith, Dr. Bagi explains AllStar Health Brands Inc.’s business model and focus on improving health and quality of life by offering select products, including medical devices, nutritional supplements, over the counter remedies...

Continue reading

Trinity Biotech announces EUA submission for Covid-19 ELISA Antibody test

DUBLIN, Ireland, Aug. 20, 2020 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets announced that it has filed its submission for an Emergency Use Authorization (EUA) for its Covid-19 IgG ELISA antibody test with the FDA. This test will determine which individuals within the population have been exposed to the SARS-CoV-2 virus. The transfer of production to our facility in Jamestown, New York is complete, our manufacturing capability is very significant and the instrumentation platforms that perform ELISA testing are available in virtually every testing laboratory in the world.The product demonstrates specificity in excess of 98% and sensitivity in excess of 95%, in samples of 14 days or more from symptom onset. EUA...

Continue reading

Regarding the decision to appeal the judgement

AB Ignitis Grupė, (hereinafter – the Company) identification code 301844044, registered office placed at Žvejų str. 14, Vilnius, Republic of Lithuania. The total nominal value of issued bonds 900 000 000 EUR; ISIN codes XS1646530565; XS1853999313; XS2177349912.The Company informs that it appealed Vilnius Regional Court (hereinafter – the Court) decision to apply the temporary protection measures and suspend mandatory buy-out of shares of AB Energijos Skirstymo Operatorius (hereinafter – ESO) until final decision in this case becomes effective.The Court announced its decision to apply temporary protection measures after receiving a claim from V. P. Vaitaitis, a shareholder of ESO on 10 August 2020.For more information: Artūras Ketlerius, Head of public relations, arturas.ketlerius@ignitis.lt

Continue reading

Dėl sprendimo skųsti teismo nutartį

AB „Ignitis grupė“ (toliau – „Ignitis grupė“ ir Bendrovė), juridinio asmens kodas: 301844044, registruotos buveinės adresas: Žvejų g. 14, Vilnius. Bendra AB „Ignitis grupė“ išleistų obligacijų nominali vertė 900 000 000 EUR; ISIN kodai: XS1646530565; XS1853999313; XS2177349912.„Ignitis grupė“ informuoja, jog pateikė atskirąjį skundą dėl Vilniaus apygardos teismo 2020 m. rugpjūčio 12 d. gautos nutarties, kuria buvo pritaikytos laikinosios apsaugos priemonės ir sustabdytas privalomas AB „Energijos skirstymo operatorius“ (toliau – ESO) akcijų išpirkimo procesas iki teismo nutarties dėl akcijų kainos nustatymo įsiteisėjimo dienos.Teismas sprendimą taikyti laikinąsias apsaugos priemones priėmė 2020 m. rugpjūčio 10 d. gavęs vieno smulkiojo „Ignitis grupės“ dukterinės bendrovės ESO akcininko V. P. Vaitaičio ieškinį.Daugiau informacijos:...

Continue reading

Atico Intercepts 12.46 g/t Au, 137g/t Ag, 9.02% Cu, and 12% Zn Over 5.64 Meters and Extends High Grade Zones Beyond Known Mineralization at LaPlata Project in Ecuador

VANCOUVER, British Columbia, Aug. 20, 2020 (GLOBE NEWSWIRE) — Atico Mining Corporation (TSX.V: ATY | OTC: ATCMF) (“Atico” or the “Company”) is pleased to announce results of the latest five holes from its drill program at the La Plata precious metals-rich volcanogenic massive sulphide (“VMS”) project in Ecuador. These five holes are still part of the ongoing campaign targeting the south block to test for possible continuity as well as mineralisation outside of the known envelope.La Plata Drilling Highlights Include:True widths are dependent on uncertainties in the local strike and dip of the mineralization and are estimated to be between 76% and 83% of the drill intercept.Joseph Salas, Atico’s VP Exploration, commented: “The high-grade precious metals results are associated with additional pulses of hydrothermal fluids that further...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.